This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
5i Sciences appoints Jan Barker as General Manager of its acute care product group and announces favorable results from a completed study in adults receiving sedation for a commonly performed medical procedure.
San Diego, CA (PRWEB) February 21, 2014
5i Sciences, a medical technology company focused on airway management products, announces the appointment of Jan Barker as General Manager of its Acute Care Product group.
This is a key appointment for our Company, said Dr. Richard Rose, CEO of 5i Sciences. Jan is a senior executive with broad experience in healthcare and managing operational growth. We have worked closely with Jan in her role as an Advisor to our Company. We are delighted that success in the development of our Acute Care Product line has created a role for someone of her stature and skill set.
Ms. Barker has held a number of executive positions in healthcare related companies. She was formerly Vice President of Stanford Childrens Hospital, regional CEO of MedPartners, Inc., COO of Alere Medical and Partner at MedVenture Associates, a venture capital firm. Ms. Barker holds a Masters Degree in Health Science from UC Davis and Stanford University.
Managing upper airway collapse is a major concern in the fields of sleep medicine and anesthesia care, said Ms. Barker. "5i Sciences proprietary cNEP technology has unique promise as a simple to use and better tolerated option for effective airway management. I'm honored to play a role in the company's growth as it brings its innovative products to these important medical markets."
The Company also announced the presentation of results from a completed study in the acute care setting at the international conference of the Society of Anesthesia and Sleep Medicine. In this study of 54 adults receiving sedation for routine colonoscopy, the application of 5i Sciences Airway Management System was safe and produced statistically significant reductions in sedation related breathing problems and improved oxygenation.
About 5i Sciences:
5i Sciences is developing its proprietary continuous negative external pressure (cNEP) technology for important medical and consumer applications. The Company is dedicated to offering simple to use, safe and well-tolerated products that keep the upper airway open. For more information, visit http://www.5iSciences.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/02/prweb11599425.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.